Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Adicionar filtros








Intervalo de ano
1.
Artigo em Inglês | IMSEAR | ID: sea-91824

RESUMO

AIM OF STUDY: Quality of life (QOL) as outcome during treatment of acid peptic disease has been studied, but, peptic perforation, which is the commonest complication of acid peptic disease, has not been studied in the light of QOL outcome. The present-study addresses the important issue of QOL after peptic perforations. METHODS: This prospective study was carried on 51 adult consecutive survivors of peptic perforation managed in Gastrointestinal Surgery Unit, Department of Surgery, Government NSCB Medical College and Hospital, Jabalpur (MP) India. These underwent exploratory laparotomy with repair of perforation, and subsequently were discharged on anti-ulcer therapy (Pantoprazole 40 mg once a day) for 6 weeks. The instrument chosen to study their QOL was gastrointestinal quality of life index (GIQLI). Patients were assessed before they underwent surgery and 3 months and 6 months after operation. RESULTS: The overall GIQLI score (t = 20.1, p < 0.00 at 3 months; t = 8.2, p < 0.001 at 6 months) as well as its G I core (t = 14.5, p < 0.001 at 3 months; t = 7.3, p < 0.001 at 6 months), G I disease specific (t = 12.9, p < 0.001 at 3 months; t = 2.6, p < 0.02 at 6 months), psychological (t = 15.4, p < 0.001 at 3 months; t = 3.5, p < 0.001 at 6 months) and physical and social components (t = 10.9, p < 0.001 at 3 months; t = 4.2, p < 0.001 at 6 months) significantly increased over 3 and 6 months of follow-up, reflecting improvement in quality of life as perceived by the patients. Variations in the pattern of recovery, based on age and gender were not seen in the present study. CONCLUSION: Peptic perforation does not result in any long lasting impairment of QOL and the QOL improves to near normal in 6 months time after the perforation.


Assuntos
2-Piridinilmetilsulfinilbenzimidazóis , Adulto , Idoso , Idoso de 80 Anos ou mais , Antiulcerosos/uso terapêutico , Benzimidazóis/uso terapêutico , Procedimentos Cirúrgicos do Sistema Digestório , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Omeprazol/análogos & derivados , Avaliação de Resultados em Cuidados de Saúde , Úlcera Péptica Perfurada/tratamento farmacológico , Estudos Prospectivos , Qualidade de Vida , Inquéritos e Questionários , Perfil de Impacto da Doença , Sulfóxidos/uso terapêutico
4.
Indian Pediatr ; 1993 Mar; 30(3): 428-9
Artigo em Inglês | IMSEAR | ID: sea-14750
7.
Indian Pediatr ; 1981 Jul; 18(7): 495-6
Artigo em Inglês | IMSEAR | ID: sea-10466
8.
Indian Pediatr ; 1981 Mar; 18(3): 193-7
Artigo em Inglês | IMSEAR | ID: sea-12676
10.
Indian Pediatr ; 1980 Aug; 17(8): 709
Artigo em Inglês | IMSEAR | ID: sea-14595
15.
Indian J Pediatr ; 1977 Sep; 44(356): 253-6
Artigo em Inglês | IMSEAR | ID: sea-83483
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA